formoterol

(redirected from Formoterol fumarate)
Also found in: Medical.
Related to Formoterol fumarate: budesonide, Salmeterol
Translations

formoterol

n formoterol m
References in periodicals archive ?
beclometasone dipropionate anhydrous / formoterol fumarate dihydrate / glycopyrronium) and Trydonis (beclometasone dipropionate anhydrous / formoterol fumarate dihydrate / glycopyrronium).
Mometasone furoate is a potent corticosteroid, and formoterol fumarate is a long-acting [beta.
The Food and Drug Administration has approved glycopyrrolate and formoterol fumarate inhalation aerosol for long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), according to a statement from AstraZeneca.
One group received a combination product, budesonide (400 [micro]g) and formoterol fumarate (6 [micro]g) as a single inhaled dose, while the other group received budesonide (400 [micro]g) inhaled dose and montelukast (10 mg) as an oral dose.
CAMBRIDGE -- Data presented at the European Respiratory Society (ERS) congress demonstrate that a new fixed-dose combination therapy of fluticasone propionate (FP), an inhaled corticosteroid, and formoterol fumarate (FORM), a long-acting beta2-agonist, is as effective in treating asthma as one of the current market leaders in Europe, fluticasone propionate/salmeterol xinafoate (FP/SAL), but has a more rapid onset of action The FP/FORM combination has also been shown to be more effective in controlling asthma symptoms than FP alone.
The fixed-dose combination of mometasone furoate and formoterol fumarate was developed by Schering-Plough and inherited by Merck when it acquired its smaller rival last year.
Contract awarded for Formoterol fumarate, Capsule with powder for inhalation 12 mcg / inhalation with dry powder inhaler unit (amparo 01200-2016-00064)
TORONTO--No long-term safety signals were seen in a randomized trial that tested the formoterol fumarate inhalation solution against placebo in patients with moderate to severe chronic obstructive pulmonary disease.
United Kingdom-based AstraZeneca has revealed positive top-line results of the Phase III, PINNACLE 4 trial in which Bevespi Aerosphere (glycopyrronium and formoterol fumarate 14.
Aclidinium bromide is a long-acting muscarinic antagonist (LAMA) and formoterol fumarate is a long-acting beta-agonist (LABA).
Those who were on monotherapy with tiotropium (Spiriva) had significantly lower rates of disease-related hospital admissions during 12 months of follow-up than those using salmeterol (Serevent), formoterol fumarate (Foradil), salmeterol / fluticasone propionate (Advair), or combination therapy with two or more LABDs, said Dr.